Skip to main content

Retail Clinics

  • Study finds link between insomnia, high insulin resistance among diabetics

    NEW YORK — Diabetics that have trouble sleeping likely experience high insulin resistance and have a more difficult time controlling the disease, according to study findings published in the June issue of Diabetes Care.

    Researchers said they monitored the sleep of 40 subjects with diabetes for a duration of six nights and also measured the subjects' insulin and glucose levels during clinical examinations. The subjects also reported if they generally suffered from symptoms of such sleep disturbances as insomnia, snoring or sleep apnea.

  • Thinksport Livestrong sunscreen hits retail

    AUSTIN, Texas — In honor of Skin Cancer Awareness Month, Thinksport and Livestrong have announced that Thinksport Livestrong sunscreen now is available online and in stores just in time for summer.

    Online retailers carrying the sunscreen include Drugstore.com, CVS.com, Thinksport.co, Amazon.com and REI.com. The sunscreen also is available at most Golfsmith and Whole Foods Market stores nationwide.

  • PhRMA: More than 850 medicines in development for diseases that disproportionately affect women

    WASHINGTON — More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

  • Study: Statin users are less adherent when multiple physicians, trips to pharmacy are involved

    NEW YORK — Patients taking cardiovascular drugs may become less adherent if they have to see multiple physicians and make frequent trips to the pharmacy, according to a new study published in the journal Archives of Internal Medicine.

    Researchers at Brigham and Women’s Hospital, Harvard Medical School in Boston and CVS Caremark analyzed data from 1.8 million patients taking statins and 1.5 million taking angiotensin receptor blockers or angiotensin-converting enzymes from between June 2006 and May 2007.

  • Researchers find TZDs may pose certain health risks for diabetics

    MARYLAND HEIGHTS, Mo. — According to a report in the May issue of Cell Metabolism, while drugs known as thiazolidinediones, or TZDs, are widely used in diabetes treatment, they have effects on the kidneys that lead to fluid retention as the volume of plasma in the bloodstream expands.

    "TZDs usually increase body weight by several kilograms," stated George Seki of the University of Tokyo. "However, TZDs sometimes cause massive volume expansion, resulting in heart failure."

  • Study: Antiretroviral therapy cuts HIV transmission risk by 96%

    WASHINGTON — Patients with HIV who immediately started antiretroviral therapy significantly reduced the risk of spreading the virus to an uninfected partner, compared with those who delayed therapy, according to results of a multinational study. The study also found that antiretroviral therapy reduced the risk of transmission by 96%.

  • Chain pharmacy supports Script Your Future campaign

    WASHINGTON — A consumer education campaign launched by the National Consumers League and the U.S. surgeon general has received support from the drug retailing industry.

    The National Association of Chain Drug Stores' charitable arm, the NACDS Foundation, engaged in the Script Your Future campaign and said it is the largest contributor to the campaign to date with its $1 million pledge.

  • Health Choices Coalition urges Congress to repeal OTC restrictions on FSAs

    WASHINGTON — The Health Choices Coalition sent a letter to members of Congress, urging them to repeal legislation that limits coverage of over-the-counter medicines.

    The coalition is looking to Congress to repeal a provision in the Patient Protection and Affordable Care Act that prevents consumers from using their flexible spending accounts to purchase OTCs without first getting a doctor's prescription. Members of the Health Choices Coalition are urging Congress to take action in order to allow consumers to use their FSAs for OTCs.

X
This ad will auto-close in 10 seconds